Strömstedt P E, Poellinger L, Gustafsson J A, Carlstedt-Duke J
Karolinska Institute, Department of Medical Nutrition, Huddinge University Hospital, Sweden.
Mol Cell Biol. 1991 Jun;11(6):3379-83. doi: 10.1128/mcb.11.6.3379-3383.1991.
Expression of the human osteocalcin promoter is negatively regulated by glucocorticoids in vivo. In vitro DNase I and exonuclease III footprinting analysis showed binding of purified glucocorticoid receptor in close proximity to and overlapping with the TATA box of the osteocalcin gene. These results imply competition or interference with binding of the TATA box-binding transcription factor IID as a mechanism of repression of this gene by glucocorticoids. In support of this notion, point mutation analysis of the receptor binding site indicated that flanking nucleotides and not the TATA box motif per se were important for receptor interaction. Moreover, DNA binding competition assays showed specific binding of the receptor only to the TATA box region of the osteocalcin gene and not to the corresponding region of an immunoglobulin heavy-chain promoter.
人骨钙素启动子的表达在体内受到糖皮质激素的负调控。体外DNA酶I和核酸外切酶III足迹分析表明,纯化的糖皮质激素受体与骨钙素基因的TATA框紧密相邻并重叠结合。这些结果表明,糖皮质激素通过与TATA框结合转录因子IID竞争或干扰其结合来抑制该基因。支持这一观点的是,受体结合位点的点突变分析表明,侧翼核苷酸而非TATA框基序本身对受体相互作用很重要。此外,DNA结合竞争试验表明,受体仅与骨钙素基因的TATA框区域特异性结合,而不与免疫球蛋白重链启动子的相应区域结合。